Moneycontrol PRO
HomeNewsFortis

Fortis

Jump to
  • Malaysia’s IHH Healthcare keeps Fortis open offer price unchanged at Rs 170/share

    Last week, IHH announced that SEBI cleared its stalled open offer for a 26.1 per cent stake in Fortis Healthcare, seven years after the Malaysian firm acquired 31.1 per cent in the Indian hospital chain.

  • Fortis to expand obesity clinics amid weight-loss therapy boom, CEO says

    Fortis, partly owned by Malaysia's IHH Healthcare, operates 28 hospitals and manages Gleneagles facilities in India.

  • Fortis Healthcare expands UP footprint with 550-bed hospital in Lucknow

    The facility, to be built near Gomti Nagar by the Ekana Group, will be positioned as a Centre of Excellence for tertiary care services.

  • Large hospital chains withstand seasonal slowdown better in June 2024 quarter

    Apollo Hospitals, Fortis Healthcare and Max Healthcare clocked decent growth in revenues despite a disruption to international patient flows

  • Fortis healthcare launches institute for specialised treatment of blood cancer, disorders

    The Fortis Institute of Blood Disorders also integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof, Fortis Healthcare said in a release.

  • Fortis partners with RED.Health to augment emergency ambulance service in Delhi-NCR

    The leading hospital group in partnership with RED.Health plan to reduce the time gap needed by a patient to avail ambulance service in critical emergency hours.

  • Sebi issues demand notices to 5 entities in Fortis Healthcare fund diversion case

    The five entities that received notices are Saubhagya Buildcon, Zolton Properties, Tiger Developers, Torus Buildcon and Rosestar Marketing.

  • Fortis to acquire Medeor's 350-bedded Hospital in Manesar Gurugram

    Currently, Fortis operates 27 healthcare facilities and the network comprises approximately 4,300 operational beds and 400 diagnostics centres.

  • Fortis Healthcare jumps 2% as diagnostic arm plans for IPO

    Moneycontrol reported on February 15 that SRL Diagnostics has opened preliminary talks with investment bankers to rope in advisers as the firm looks to launch an IPO to raise around Rs 2,000 crore

  • SC to hear bail plea of ex-Fortis promoter Malvinder Mohan Singh

    The top court issued notice to the standing counsel of the Delhi government and posted the plea for hearing at 1 pm.

  • SC likely to pronounce verdict on IHH open offer for Fortis tomorrow

    Japanese drugmaker Daiichi Sankyo had challenged the Fortis-IHH deal to recover the Rs 3,600 crore arbitration award it had won in a Singapore tribunal against Fortis’ erstwhile promoters

  • SAT directs Malvinder Mohan Singh, Malav Holdings to deposit 50% of Sebi penalty amount

    In a case involving Fortis Healthcare, the Securities Appellate Tribunal (SAT) has ordered businessman Malvinder Mohan Singh and Malav Holdings to deposit 50% of the penalty amount levied by markets regulator Sebi within six weeks.

  • CGHS dues exceed Rs 1,000 crore, private hospitals threaten to stop cashless treatment facility

    CGHS covers all current and retired central government employees and their families. Their user base is estimated to be around 40 lakh

  • Molnupiravir more effective against Omicron, claims new study

    Even as the third wave of COVID-19 pandemic subsides in India and most cases are reported to be mild, a new study has said that Molnupiravir, granted regulatory approval in the country in December, 2021 can be useful for patients at risk of disease progression.

  • Right time to act and ensure no community transmission of Omicron happens: Fortis Healthcare CEO

    Dr Ashutosh Raghuvanshi, the Managing Director and CEO of Fortis Healthcare, says case there is any new wave or increase in cases in certain pockets, facilities like telemedicine, E-ICUs will help us provide continuous treatment to the patients.

  • Fortis rolls out online consultations across 23 hospitals amid lockdown

    As the country continues with its lockdown, the step was conceived to continue patient care services without risking the health of patients or doctors

  • Corporate Buzz podcast | Essar Steel verdict; more trouble for Vodafone Idea and Airtel; and the Singh brothers saga

    Moneycontrol's Jerome Anthony talks to Corporate Bureau Chief Prince Thomas to find out the top developments in the corporate world.

  • Policy | If the ‘market knows’, why doesn’t the auditor?

    Does the audit industry consider its responsibility towards a company’s stakeholders while writing out scripted audit reports? There needs to be a systemic focus on improving audit quality standards.

  • Delhi court sends ex-Fortis promoters Malvinder, Shivinder to 14-day judicial custody

    Metropolitan Magistrate Nishant Garg also sent three others, Sunil Godhwani, Kavi Arora and Anil Saxena to judicial custody till October 31.

  • Fortis Healthcare shareholders approve stake sale of Mauritius hospitals

    Fortis has 28.89 percent stake in MSCL, while Mauritius-based CIEL Healthcare holds 58.60, and the remaining is held by other shareholders

  • Podcast | Digging Deeper: The Singh brothers and the saga of Fortis

    On this edition of Digging Deeper with Moneycontrol, we listen to the ballad of the bhais that went bust. The saga of the Singh brothers.

  • Supreme Court puts Fortis Healthcare sale to IHH on hold

    The order came after Daiichi Sankyo filed a contempt plea against Fortis' former promoters Malvinder Singh and Shivinder Singh (Singh brothers)

  • SEBI asks Singh brothers, 8 others to repay Rs 403 cr to Fortis within 3 months

    SEBI has directed the Singh brothers to not associate themselves with the affairs of Fortis Healthcare (FHL) in any manner till further directions

  • Opinion | The Fortis-Religare episode is a fit case for India's first class-action suit

    A class action suit is one that allows a large number of people having a common cause of action to jointly file or pursue a litigation.

  • Twist in tale: Religare Enterprises moves NCLT to recover siphoned funds from Singh Brothers

    Former Ranbaxy promoter and Fortis founder Shivinder Singh had alleged about these financial irregularities in his letter earlier this month.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347